223 related articles for article (PubMed ID: 28044367)
1. Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata.
Özdemir M; Balevi A
Pediatr Dermatol; 2017 Mar; 34(2):128-132. PubMed ID: 28044367
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
[TBL] [Abstract][Full Text] [Related]
3. Bilateral treatment for alopecia areata.
Torchia D; Schachner LA
Pediatr Dermatol; 2010; 27(4):415-6. PubMed ID: 20653874
[TBL] [Abstract][Full Text] [Related]
4. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study.
Sasmaz S; Arican O
Am J Clin Dermatol; 2005; 6(6):403-6. PubMed ID: 16343028
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Durdu M; Özcan D; Baba M; Seçkin D
J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
[TBL] [Abstract][Full Text] [Related]
6. A Retrospective Review of Anthralin in Petrolatum in the Treatment of Alopecia Areata in the Pediatric Population.
Zafrir Y; Tantuco K; Tangtatco AJA; Ho N
J Cutan Med Surg; 2023; 27(5):449-453. PubMed ID: 37559401
[TBL] [Abstract][Full Text] [Related]
7. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
Tang L; Cao L; Sundberg JP; Lui H; Shapiro J
Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
[TBL] [Abstract][Full Text] [Related]
9. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
Kagami S; Kishi Y; Hino H
J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
Ibrahim SA; Esawy AM; Abdelshafy AS
Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
[TBL] [Abstract][Full Text] [Related]
11. Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata.
Ngwanya MR; Gray NA; Gumedze F; Ndyenga A; Khumalo NP
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28598005
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
[TBL] [Abstract][Full Text] [Related]
13. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anthralin in the treatment of alopecia areata.
Fiedler-Weiss VC; Buys CM
Arch Dermatol; 1987 Nov; 123(11):1491-3. PubMed ID: 3314718
[TBL] [Abstract][Full Text] [Related]
15. A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low-level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow-up based on clinical studies.
Behrangi E; Roohaninasab M; Sadeghzadeh-Bazargan A; Najar Nobari N; Ghassemi M; Seirafianpour F; Goodarzi A; Dodangeh M
J Cosmet Dermatol; 2022 Jul; 21(7):2727-2741. PubMed ID: 34606676
[TBL] [Abstract][Full Text] [Related]
16. Alopecia areata.
Perera E; Yip L; Sinclair R
Curr Probl Dermatol; 2015; 47():67-75. PubMed ID: 26370645
[TBL] [Abstract][Full Text] [Related]
17. Recalcitrant alopecia areata responsive to leflunomide and anthralin-Potentially undiscovered JAK/STAT inhibitors?
Sardana K; Gupta A; Gautam RK
Pediatr Dermatol; 2018 Nov; 35(6):856-858. PubMed ID: 30318623
[TBL] [Abstract][Full Text] [Related]
18. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
19. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
20. Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study.
Thuangtong R; Suvansuthi S; Maneeprasopchoke P; Sukakul T; Techakajornkeart R; Chaweekulrat P; Wongdama S; Triwongwaranat D
Int J Trichology; 2022; 14(3):91-96. PubMed ID: 35755959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
